EUVIMEDEUVIMED entdecken
Fallbericht

Treatment of Refractory Melasma with Oral Tranexamic acid: A Case Report

International Journal of Clinical & Experimental Dermatology · 2019

DOI: 10.33140/ijced.04.01.06 ↗

Kurz gefasst

Fallbericht in der Zeitschrift International Journal of Clinical & Experimental Dermatology, 2019. Die Arbeit nennt 35 Literaturangaben.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Melasma, an acquired disorder of hyperpigmentation is common in Indians. Though topical skin lightening agents are available, the success rates are often variable. Management of melasma is a challenge and the search for a safe and effective therapy continues. Many studies suggested the use of oral tranexamic acid (TA) as a treatment modality for melasma. Herein we report a case of female patient with refractory melasma who showed an improvement with a combination of oral tranexamic acid 250 mg and pine bark extract 50 mg twice daily during 8 weeks treatment period. Also, there was no recurrence seen in 3 month follow-up period. This treatment modality was well tolerated.

Zitieren

APA

(2019). Treatment of Refractory Melasma with Oral Tranexamic acid: A Case Report. International Journal of Clinical & Experimental Dermatology. https://doi.org/10.33140/ijced.04.01.06

Vancouver

Treatment of Refractory Melasma with Oral Tranexamic acid: A Case Report. International Journal of Clinical & Experimental Dermatology. 2019. doi:10.33140/ijced.04.01.06

BibTeX
@article{euvimed2019,
  title = {Treatment of Refractory Melasma with Oral Tranexamic acid: A Case Report},
  journal = {International Journal of Clinical & Experimental Dermatology},
  year = {2019},
  doi = {10.33140/ijced.04.01.06}
}
Kostenlos starten →